Accessibility Menu
 

Imv

(OTC) IMVIF

Current Price$0.00
Market CapN/A
Since IPO (2012)-100%
5 Year-100%
1 Year+0%
1 Month+0%

Imv Financials at a Glance

Market Cap

N/A

Revenue (TTM)

$0.00

Net Income (TTM)

$37.53M

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Price

$0.00

Volume

1

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.02

IMVIF News

IMVIF: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Imv

Industry

Biotechnology

Employees

97

CEO

Andrew Hall

Headquarters

Dartmouth, NS B3B 2C4, CA

IMVIF Financials

Key Financial Metrics (TTM)

Gross Margin

0%

Operating Margin

0%

Net Income Margin

0%

Return on Equity

0%

Return on Capital

-2%

Return on Assets

-1%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$0.00

Shares Outstanding

0

Volume

1

Short Interest

0.00%

Avg. Volume

1.661

Financials (TTM)

Gross Profit

$962.30K

Operating Income

$38.67M

EBITDA

$35.52M

Operating Cash Flow

$32.07M

Capital Expenditure

$1.07M

Free Cash Flow

$33.10M

Cash & ST Invst.

$21.21M

Total Debt

$28.90M

Imv Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2022YOY CHG

Revenue

$0.00

N/A

Gross Profit

$322.49K

-54.1%

Gross Margin

0.00%

N/A

Market Cap

$0.00

N/A

Market Cap/Employee

N/A

N/A

Employees

63

N/A

Net Income

$8.63M

+26.0%

EBITDA

$8.27M

+25.2%

Quarterly Fundamentals

Name
Q4 2022YOY CHG

Net Cash

$7.68M

-140.6%

Accounts Receivable

$1.92M

+206.4%

Inventory

$2.00

+0.0%

Long Term Debt

$28.52M

+47.8%

Short Term Debt

$367.00K

+8.6%

Return on Assets

-1.16%

N/A

Return on Invested Capital

-1.76%

N/A

Free Cash Flow

$6.51M

+18.4%

Operating Cash Flow

$6.30M

+14.2%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
EFTReFFECTOR Therapeutics, Inc.
$0.00+0.00%
CFRXQContraFect Corporation
$0.00+0.00%
OMMHOmnimmune Holdings, Inc.
$0.00+0.00%
DMKPQDMK Pharmaceuticals Corporation
$0.00+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
TQQQProShares Trust - ProShares UltraPro Qqq
$38.78-0.06%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$8.28+0.05%
QQQInvesco QQQ Trust
$562.58-0.02%
ARTLArtelo Biosciences
$10.54+2.30%

Questions About IMVIF

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.